Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells (2016)
- Autores:
- Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1158/1535-7163.MCT-15-0742
- Assunto: MICROBIOLOGIA
- Idioma: Inglês
- Imprenta:
- Local: Philadelphia
- Data de publicação: 2016
- Fonte:
- Título do periódico: Molecular Cancer Therapeuthics
- ISSN: 1538-8514
- Volume/Número/Paginação/Ano: v. 15, n. 8, p. 1920-1930, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
DINIZ, Mariana O. et al. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells. Molecular Cancer Therapeuthics, v. 15, n. 8, p. 1920-1930, 2016Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.MCT-15-0742. Acesso em: 24 abr. 2024. -
APA
Diniz, M. O., Sales, N. S., Silva, J. R., & Ferreira, L. C. de S. (2016). Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells. Molecular Cancer Therapeuthics, 15( 8), 1920-1930. doi:10.1158/1535-7163.MCT-15-0742 -
NLM
Diniz MO, Sales NS, Silva JR, Ferreira LC de S. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells [Internet]. Molecular Cancer Therapeuthics. 2016 ; 15( 8): 1920-1930.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1158/1535-7163.MCT-15-0742 -
Vancouver
Diniz MO, Sales NS, Silva JR, Ferreira LC de S. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells [Internet]. Molecular Cancer Therapeuthics. 2016 ; 15( 8): 1920-1930.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1158/1535-7163.MCT-15-0742 - Avaliação das propriedades imunológicas e papel vacinal da flagelina fliCi de Salmonella enterica pv Typhimurium
- Expression of enterotoxigenic Escherichia coli proteins by genetically modified Bacillus subtilis strains as a new approach to develop mucosal vaccines
- Immunogenicity of flagelins FliCi e FliCd following oral immunization of mice with attenuated salmonella strains
- Evaluation of the genetic diversity among enterotoxigenic Escherichia coli (ETEC) strains isolated from humans in Brazil and Argentina
- Construção de uma vacina de DNA bivalente contra os vírus do papiloma e herpes simplex humano
- A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model
- Produção e purificação da flagelina FliCi de S. Typhimurium
- Surface expression of adhesins enhances the vaccine potential of orally delivered Bacillus subtilis strains
- Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D
- Characterization of a DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the N-terminal domain of Salmonella enterica SV Müenchen FLICd flagellin
Informações sobre o DOI: 10.1158/1535-7163.MCT-15-0742 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
